Same Quality, Safety and Efficacy
as the Brand-Name
as the Brand-Name
All drugs, both brand-name and generics, are reviewed and authorized for sale by Health Canada before they are available for prescription. When a generic drug is approved, Health Canada continues to monitor its safety, effectiveness, and quality. Generic medicines are required to work the same way in the body as the original brand-name drug.
Generic medicines have the same active ingredient as the brand-name and must have the same amount of active ingredient in the prescription. Non-medicinal ingredients, like fillers and preservatives, may be different from the brand-name product, but they are also regulated and reviewed by Health Canada. To receive a license to manufacture and sell drugs in Canada, both brand-name and generic drug companies must follow the same Good Manufacturing Practices (GMP) guidelines, which ensure consistent production and quality standards.
CGPA member companies manufacture and market hundreds of different types of high-quality, cost-saving prescription medicines including solid oral drugs in the form of pills and tablets, non-solid products such as injectables and prescription creams and ointments.
What is Bioequivalence?
In Canada bioequivalence testing is based on internationally recognized scientific methodologies and standards. If a generic drug product is tested and is bioequivalent to the brand-name version, there is no meaningful difference between the brand-name and the generic and the way the generic medicine works in the body. A bioequivalent generic drug is as safe and as effective as the brand-name version. The scientists who work at Health Canada and the expert panelists they consult ensure that bioequivalence lab tests follow the most current and rigorous scientific standards.